Free Trial

Enovix (NASDAQ:ENVX) Trading Up 5.7% - Here's What Happened

Enovix logo with Energy background

Enovix Corporation (NASDAQ:ENVX - Get Free Report)'s stock price rose 5.7% during trading on Tuesday . The stock traded as high as $16.23 and last traded at $15.49. Approximately 7,352,856 shares were traded during mid-day trading, an increase of 23% from the average daily volume of 5,967,617 shares. The stock had previously closed at $14.65.

Analysts Set New Price Targets

Several research firms have recently commented on ENVX. TD Securities lowered their target price on Enovix from $10.00 to $7.00 and set a "hold" rating for the company in a report on Thursday, May 1st. Benchmark decreased their price target on Enovix from $25.00 to $15.00 and set a "buy" rating for the company in a research note on Tuesday, April 15th. JPMorgan Chase & Co. decreased their price target on Enovix from $10.00 to $9.00 and set an "overweight" rating for the company in a research note on Thursday, May 1st. B. Riley restated a "buy" rating and issued a $17.00 target price (up previously from $12.00) on shares of Enovix in a report on Thursday, July 10th. Finally, Wall Street Zen upgraded Enovix from a "sell" rating to a "hold" rating in a report on Saturday, July 12th. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $17.55.

View Our Latest Stock Report on Enovix

Enovix Trading Up 5.5%

The firm has a market capitalization of $3.06 billion, a price-to-earnings ratio of -12.35 and a beta of 2.09. The business has a 50-day moving average of $9.39 and a two-hundred day moving average of $9.18. The company has a quick ratio of 4.49, a current ratio of 4.68 and a debt-to-equity ratio of 0.71.

Enovix announced that its board has authorized a share repurchase program on Wednesday, July 2nd that permits the company to buyback $60.00 million in outstanding shares. This buyback authorization permits the company to repurchase up to 3.1% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's leadership believes its shares are undervalued.

Institutional Investors Weigh In On Enovix

A number of institutional investors have recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. boosted its holdings in Enovix by 9.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,348,340 shares of the company's stock valued at $14,656,000 after purchasing an additional 119,288 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in Enovix by 6.8% during the fourth quarter. Victory Capital Management Inc. now owns 19,695 shares of the company's stock valued at $214,000 after purchasing an additional 1,257 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Enovix during the fourth quarter valued at approximately $3,484,000. Avantax Advisory Services Inc. boosted its holdings in Enovix by 82.9% during the fourth quarter. Avantax Advisory Services Inc. now owns 60,162 shares of the company's stock valued at $654,000 after purchasing an additional 27,274 shares in the last quarter. Finally, Swiss National Bank boosted its holdings in Enovix by 4.7% during the fourth quarter. Swiss National Bank now owns 294,700 shares of the company's stock valued at $3,203,000 after purchasing an additional 13,100 shares in the last quarter. 50.92% of the stock is owned by institutional investors and hedge funds.

About Enovix

(Get Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Read More

Should You Invest $1,000 in Enovix Right Now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines